Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Maanshan Tongxing Pharmaceutical is a specialized pharmaceutical manufacturer based in Maanshan, Anhui Province, China, and operates as a subsidiary of China Resources Double-Crane Pharmaceutical. The company focuses on the production of chemical active pharmaceutical ingredients (APIs) and finished oral solid dosage forms, with a primary therapeutic emphasis on chronic disease management. Its product portfolio is heavily weighted toward endocrinology and cardiovascular health, featuring essential medicines such as Metformin Hydrochloride and Gliclazide for diabetes. Maanshan Tongxing maintains modern, GMP-certified manufacturing facilities that support the broader supply chain of its parent company, China Resources. The firm plays a significant role in providing high-quality, affordable generic medications to the Chinese domestic market.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Maanshan Tongxing Pharmaceutical.